nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—systemic scleroderma—Nifedipine—hypertension	0.324	1	CpDpCtD
Tadalafil—PDE5A—hypertension	0.31	1	CbGaD
Tadalafil—CYP3A4—Guanethidine—hypertension	0.0154	0.11	CbGbCtD
Tadalafil—CYP3A4—Hydralazine—hypertension	0.0117	0.0837	CbGbCtD
Tadalafil—CYP3A4—Guanfacine—hypertension	0.00991	0.0712	CbGbCtD
Tadalafil—CYP3A4—Isradipine—hypertension	0.00883	0.0634	CbGbCtD
Tadalafil—CYP3A4—Indapamide—hypertension	0.00778	0.0558	CbGbCtD
Tadalafil—CYP3A4—Nisoldipine—hypertension	0.00778	0.0558	CbGbCtD
Tadalafil—CYP3A4—Diltiazem—hypertension	0.00751	0.0539	CbGbCtD
Tadalafil—CYP3A4—Eplerenone—hypertension	0.00751	0.0539	CbGbCtD
Tadalafil—CYP3A4—Enalapril—hypertension	0.0067	0.0481	CbGbCtD
Tadalafil—CYP3A4—Irbesartan—hypertension	0.00612	0.044	CbGbCtD
Tadalafil—CYP3A4—Amlodipine—hypertension	0.00601	0.0431	CbGbCtD
Tadalafil—CYP3A4—Felodipine—hypertension	0.00579	0.0416	CbGbCtD
Tadalafil—CYP3A4—Nifedipine—hypertension	0.0056	0.0402	CbGbCtD
Tadalafil—CYP3A4—Carvedilol—hypertension	0.00551	0.0396	CbGbCtD
Tadalafil—CYP3A4—Nicardipine—hypertension	0.00551	0.0396	CbGbCtD
Tadalafil—PDE5A—pulmonary artery—hypertension	0.00534	0.266	CbGeAlD
Tadalafil—CYP3A4—Propranolol—hypertension	0.00507	0.0364	CbGbCtD
Tadalafil—CYP3A4—Clonidine—hypertension	0.00484	0.0348	CbGbCtD
Tadalafil—CYP3A4—Atorvastatin—hypertension	0.00431	0.031	CbGbCtD
Tadalafil—CYP3A4—Losartan—hypertension	0.00395	0.0283	CbGbCtD
Tadalafil—CYP3A4—Verapamil—hypertension	0.00348	0.025	CbGbCtD
Tadalafil—PDE5A—artery—hypertension	0.00198	0.0986	CbGeAlD
Tadalafil—PDE11A—heart—hypertension	0.00192	0.0954	CbGeAlD
Tadalafil—PDE5A—endothelium—hypertension	0.00167	0.0833	CbGeAlD
Tadalafil—PDE5A—blood vessel—hypertension	0.00154	0.0768	CbGeAlD
Tadalafil—PDE11A—adrenal gland—hypertension	0.00143	0.0712	CbGeAlD
Tadalafil—PDE11A—endocrine gland—hypertension	0.00124	0.0618	CbGeAlD
Tadalafil—CYP3A4—urine—hypertension	0.000888	0.0442	CbGeAlD
Tadalafil—PDE5A—heart—hypertension	0.000729	0.0363	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—hypertension	0.000724	0.036	CbGeAlD
Tadalafil—PDE5A—cardiovascular system—hypertension	0.000688	0.0343	CbGeAlD
Tadalafil—PDE5A—adrenal gland—hypertension	0.000544	0.0271	CbGeAlD
Tadalafil—PDE5A—endocrine gland—hypertension	0.000472	0.0235	CbGeAlD
Tadalafil—PDE5A—central nervous system—hypertension	0.000425	0.0212	CbGeAlD
Tadalafil—CYP3A4—kidney—hypertension	0.00021	0.0105	CbGeAlD
Tadalafil—CYP3A4—endocrine gland—hypertension	0.000147	0.00733	CbGeAlD
Tadalafil—CYP3A4—central nervous system—hypertension	0.000133	0.0066	CbGeAlD
Tadalafil—Vomiting—Nifedipine—hypertension	1.81e-05	0.000135	CcSEcCtD
Tadalafil—Gastrointestinal pain—Furosemide—hypertension	1.81e-05	0.000135	CcSEcCtD
Tadalafil—Rash—Eplerenone—hypertension	1.81e-05	0.000135	CcSEcCtD
Tadalafil—Urticaria—Perindopril—hypertension	1.81e-05	0.000135	CcSEcCtD
Tadalafil—Headache—Fosinopril—hypertension	1.81e-05	0.000135	CcSEcCtD
Tadalafil—Hypersensitivity—Trandolapril—hypertension	1.81e-05	0.000135	CcSEcCtD
Tadalafil—Dermatitis—Eplerenone—hypertension	1.81e-05	0.000134	CcSEcCtD
Tadalafil—Diarrhoea—Valsartan—hypertension	1.81e-05	0.000134	CcSEcCtD
Tadalafil—Asthenia—Clonidine—hypertension	1.81e-05	0.000134	CcSEcCtD
Tadalafil—Vomiting—Verapamil—hypertension	1.81e-05	0.000134	CcSEcCtD
Tadalafil—Urticaria—Irbesartan—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Shock—Ramipril—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Hypersensitivity—Enalapril—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Abdominal pain—Perindopril—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Palpitations—Lisinopril—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Diarrhoea—Olmesartan—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Headache—Eplerenone—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Rash—Nifedipine—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Nervous system disorder—Ramipril—hypertension	1.8e-05	0.000134	CcSEcCtD
Tadalafil—Dermatitis—Nifedipine—hypertension	1.8e-05	0.000133	CcSEcCtD
Tadalafil—Abdominal pain—Irbesartan—hypertension	1.8e-05	0.000133	CcSEcCtD
Tadalafil—Oedema—Timolol—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Loss of consciousness—Lisinopril—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Rash—Verapamil—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Urticaria—Hydrochlorothiazide—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Tachycardia—Ramipril—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Dermatitis—Verapamil—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Headache—Nifedipine—hypertension	1.79e-05	0.000133	CcSEcCtD
Tadalafil—Pruritus—Clonidine—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Abdominal pain—Hydrochlorothiazide—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Skin disorder—Ramipril—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Infection—Timolol—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Headache—Verapamil—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Hypersensitivity—Telmisartan—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Cough—Lisinopril—hypertension	1.78e-05	0.000132	CcSEcCtD
Tadalafil—Nausea—Diltiazem—hypertension	1.77e-05	0.000132	CcSEcCtD
Tadalafil—Nausea—Indapamide—hypertension	1.77e-05	0.000132	CcSEcCtD
Tadalafil—Hyperhidrosis—Ramipril—hypertension	1.77e-05	0.000132	CcSEcCtD
Tadalafil—Asthenia—Trandolapril—hypertension	1.76e-05	0.000131	CcSEcCtD
Tadalafil—Shock—Timolol—hypertension	1.76e-05	0.000131	CcSEcCtD
Tadalafil—Urticaria—Furosemide—hypertension	1.76e-05	0.000131	CcSEcCtD
Tadalafil—Nervous system disorder—Timolol—hypertension	1.76e-05	0.000131	CcSEcCtD
Tadalafil—Nausea—Carvedilol—hypertension	1.76e-05	0.000131	CcSEcCtD
Tadalafil—Asthenia—Enalapril—hypertension	1.76e-05	0.00013	CcSEcCtD
Tadalafil—Abdominal pain—Furosemide—hypertension	1.75e-05	0.00013	CcSEcCtD
Tadalafil—Gastrointestinal pain—Losartan—hypertension	1.75e-05	0.00013	CcSEcCtD
Tadalafil—Dizziness—Valsartan—hypertension	1.75e-05	0.00013	CcSEcCtD
Tadalafil—Urticaria—Betaxolol—hypertension	1.74e-05	0.000129	CcSEcCtD
Tadalafil—Skin disorder—Timolol—hypertension	1.74e-05	0.000129	CcSEcCtD
Tadalafil—Dizziness—Olmesartan—hypertension	1.74e-05	0.000129	CcSEcCtD
Tadalafil—Pruritus—Trandolapril—hypertension	1.74e-05	0.000129	CcSEcCtD
Tadalafil—Nausea—Doxazosin—hypertension	1.74e-05	0.000129	CcSEcCtD
Tadalafil—Arthralgia—Lisinopril—hypertension	1.73e-05	0.000129	CcSEcCtD
Tadalafil—Myalgia—Lisinopril—hypertension	1.73e-05	0.000129	CcSEcCtD
Tadalafil—Chest pain—Lisinopril—hypertension	1.73e-05	0.000129	CcSEcCtD
Tadalafil—Hyperhidrosis—Timolol—hypertension	1.73e-05	0.000129	CcSEcCtD
Tadalafil—Asthenia—Telmisartan—hypertension	1.73e-05	0.000129	CcSEcCtD
Tadalafil—Pruritus—Enalapril—hypertension	1.73e-05	0.000129	CcSEcCtD
Tadalafil—Diarrhoea—Clonidine—hypertension	1.72e-05	0.000128	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.72e-05	0.000128	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	1.72e-05	0.000241	CbGpPWpGaD
Tadalafil—Nausea—Fosinopril—hypertension	1.72e-05	0.000128	CcSEcCtD
Tadalafil—Discomfort—Lisinopril—hypertension	1.71e-05	0.000127	CcSEcCtD
Tadalafil—Hypotension—Ramipril—hypertension	1.71e-05	0.000127	CcSEcCtD
Tadalafil—Pruritus—Telmisartan—hypertension	1.71e-05	0.000127	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	1.71e-05	0.00024	CbGpPWpGaD
Tadalafil—Nausea—Eplerenone—hypertension	1.71e-05	0.000127	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CALM2—hypertension	1.7e-05	0.000239	CbGpPWpGaD
Tadalafil—Urticaria—Losartan—hypertension	1.7e-05	0.000126	CcSEcCtD
Tadalafil—Dry mouth—Lisinopril—hypertension	1.7e-05	0.000126	CcSEcCtD
Tadalafil—Nausea—Nifedipine—hypertension	1.69e-05	0.000126	CcSEcCtD
Tadalafil—Abdominal pain—Losartan—hypertension	1.69e-05	0.000126	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—TBXAS1—hypertension	1.69e-05	0.000237	CbGpPWpGaD
Tadalafil—Nausea—Verapamil—hypertension	1.69e-05	0.000125	CcSEcCtD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	1.69e-05	0.000237	CbGpPWpGaD
Tadalafil—Asthenia—Captopril—hypertension	1.68e-05	0.000125	CcSEcCtD
Tadalafil—Diarrhoea—Trandolapril—hypertension	1.68e-05	0.000125	CcSEcCtD
Tadalafil—Vomiting—Valsartan—hypertension	1.68e-05	0.000125	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AKT2—hypertension	1.68e-05	0.000236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD2—hypertension	1.68e-05	0.000235	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR7—hypertension	1.68e-05	0.000235	CbGpPWpGaD
Tadalafil—Diarrhoea—Enalapril—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Hypotension—Timolol—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Hypersensitivity—Irbesartan—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Vomiting—Olmesartan—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Ramipril—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Rash—Valsartan—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Dizziness—Clonidine—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Dermatitis—Valsartan—hypertension	1.67e-05	0.000124	CcSEcCtD
Tadalafil—Oedema—Lisinopril—hypertension	1.66e-05	0.000124	CcSEcCtD
Tadalafil—Pruritus—Captopril—hypertension	1.66e-05	0.000123	CcSEcCtD
Tadalafil—Hypersensitivity—Hydrochlorothiazide—hypertension	1.66e-05	0.000123	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GCG—hypertension	1.66e-05	0.000233	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTPN1—hypertension	1.66e-05	0.000233	CbGpPWpGaD
Tadalafil—Rash—Olmesartan—hypertension	1.66e-05	0.000123	CcSEcCtD
Tadalafil—Insomnia—Ramipril—hypertension	1.66e-05	0.000123	CcSEcCtD
Tadalafil—Dermatitis—Olmesartan—hypertension	1.66e-05	0.000123	CcSEcCtD
Tadalafil—Headache—Valsartan—hypertension	1.66e-05	0.000123	CcSEcCtD
Tadalafil—Diarrhoea—Telmisartan—hypertension	1.65e-05	0.000123	CcSEcCtD
Tadalafil—Infection—Lisinopril—hypertension	1.65e-05	0.000123	CcSEcCtD
Tadalafil—Headache—Olmesartan—hypertension	1.65e-05	0.000122	CcSEcCtD
Tadalafil—Paraesthesia—Ramipril—hypertension	1.65e-05	0.000122	CcSEcCtD
Tadalafil—Shock—Lisinopril—hypertension	1.64e-05	0.000122	CcSEcCtD
Tadalafil—Asthenia—Perindopril—hypertension	1.64e-05	0.000122	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—EP300—hypertension	1.64e-05	0.00023	CbGpPWpGaD
Tadalafil—Dyspnoea—Ramipril—hypertension	1.63e-05	0.000121	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Timolol—hypertension	1.63e-05	0.000121	CcSEcCtD
Tadalafil—Hypersensitivity—Furosemide—hypertension	1.63e-05	0.000121	CcSEcCtD
Tadalafil—Asthenia—Irbesartan—hypertension	1.63e-05	0.000121	CcSEcCtD
Tadalafil—Somnolence—Ramipril—hypertension	1.63e-05	0.000121	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—NOTCH2—hypertension	1.63e-05	0.000229	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KL—hypertension	1.63e-05	0.000229	CbGpPWpGaD
Tadalafil—Dizziness—Trandolapril—hypertension	1.63e-05	0.000121	CcSEcCtD
Tadalafil—Tachycardia—Lisinopril—hypertension	1.62e-05	0.000121	CcSEcCtD
Tadalafil—Insomnia—Timolol—hypertension	1.62e-05	0.00012	CcSEcCtD
Tadalafil—Dizziness—Enalapril—hypertension	1.62e-05	0.00012	CcSEcCtD
Tadalafil—Asthenia—Hydrochlorothiazide—hypertension	1.62e-05	0.00012	CcSEcCtD
Tadalafil—Hypersensitivity—Betaxolol—hypertension	1.62e-05	0.00012	CcSEcCtD
Tadalafil—Skin disorder—Lisinopril—hypertension	1.61e-05	0.00012	CcSEcCtD
Tadalafil—Dyspepsia—Ramipril—hypertension	1.61e-05	0.00012	CcSEcCtD
Tadalafil—Pruritus—Perindopril—hypertension	1.61e-05	0.00012	CcSEcCtD
Tadalafil—Paraesthesia—Timolol—hypertension	1.61e-05	0.00012	CcSEcCtD
Tadalafil—Pruritus—Irbesartan—hypertension	1.61e-05	0.000119	CcSEcCtD
Tadalafil—Hyperhidrosis—Lisinopril—hypertension	1.61e-05	0.000119	CcSEcCtD
Tadalafil—Diarrhoea—Captopril—hypertension	1.61e-05	0.000119	CcSEcCtD
Tadalafil—Vomiting—Clonidine—hypertension	1.6e-05	0.000119	CcSEcCtD
Tadalafil—Dyspnoea—Timolol—hypertension	1.6e-05	0.000119	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ITGAV—hypertension	1.6e-05	0.000224	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGFR—hypertension	1.6e-05	0.000224	CbGpPWpGaD
Tadalafil—Dizziness—Telmisartan—hypertension	1.6e-05	0.000119	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—TGFB1—hypertension	1.59e-05	0.000224	CbGpPWpGaD
Tadalafil—Pruritus—Hydrochlorothiazide—hypertension	1.59e-05	0.000118	CcSEcCtD
Tadalafil—Somnolence—Timolol—hypertension	1.59e-05	0.000118	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—KNG1—hypertension	1.59e-05	0.000224	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SRC—hypertension	1.59e-05	0.000223	CbGpPWpGaD
Tadalafil—Asthenia—Furosemide—hypertension	1.59e-05	0.000118	CcSEcCtD
Tadalafil—Rash—Clonidine—hypertension	1.59e-05	0.000118	CcSEcCtD
Tadalafil—Dermatitis—Clonidine—hypertension	1.59e-05	0.000118	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—POMC—hypertension	1.59e-05	0.000223	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR1—hypertension	1.58e-05	0.000222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRL—hypertension	1.58e-05	0.000222	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Ramipril—hypertension	1.58e-05	0.000118	CcSEcCtD
Tadalafil—Fatigue—Ramipril—hypertension	1.58e-05	0.000117	CcSEcCtD
Tadalafil—Headache—Clonidine—hypertension	1.58e-05	0.000117	CcSEcCtD
Tadalafil—Dyspepsia—Timolol—hypertension	1.58e-05	0.000117	CcSEcCtD
Tadalafil—Hypersensitivity—Losartan—hypertension	1.58e-05	0.000117	CcSEcCtD
Tadalafil—Asthenia—Betaxolol—hypertension	1.57e-05	0.000117	CcSEcCtD
Tadalafil—Nausea—Valsartan—hypertension	1.57e-05	0.000117	CcSEcCtD
Tadalafil—Pruritus—Furosemide—hypertension	1.57e-05	0.000116	CcSEcCtD
Tadalafil—Constipation—Ramipril—hypertension	1.57e-05	0.000116	CcSEcCtD
Tadalafil—Nausea—Olmesartan—hypertension	1.56e-05	0.000116	CcSEcCtD
Tadalafil—Vomiting—Trandolapril—hypertension	1.56e-05	0.000116	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—STK11—hypertension	1.56e-05	0.000219	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HDAC1—hypertension	1.56e-05	0.000219	CbGpPWpGaD
Tadalafil—Diarrhoea—Perindopril—hypertension	1.56e-05	0.000116	CcSEcCtD
Tadalafil—Vomiting—Enalapril—hypertension	1.56e-05	0.000116	CcSEcCtD
Tadalafil—Diarrhoea—Irbesartan—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—Hypotension—Lisinopril—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—hypertension	1.55e-05	0.000218	CbGpPWpGaD
Tadalafil—Dizziness—Captopril—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—Pruritus—Betaxolol—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—Rash—Trandolapril—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—VEGFA—hypertension	1.55e-05	0.000217	CbGpPWpGaD
Tadalafil—Dermatitis—Trandolapril—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Timolol—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CXCL10—hypertension	1.55e-05	0.000217	CbGpPWpGaD
Tadalafil—Fatigue—Timolol—hypertension	1.55e-05	0.000115	CcSEcCtD
Tadalafil—Rash—Enalapril—hypertension	1.54e-05	0.000115	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PLG—hypertension	1.54e-05	0.000217	CbGpPWpGaD
Tadalafil—Dermatitis—Enalapril—hypertension	1.54e-05	0.000115	CcSEcCtD
Tadalafil—Diarrhoea—Hydrochlorothiazide—hypertension	1.54e-05	0.000115	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—RHOA—hypertension	1.54e-05	0.000216	CbGpPWpGaD
Tadalafil—Headache—Trandolapril—hypertension	1.54e-05	0.000114	CcSEcCtD
Tadalafil—Vomiting—Telmisartan—hypertension	1.54e-05	0.000114	CcSEcCtD
Tadalafil—Asthenia—Losartan—hypertension	1.53e-05	0.000114	CcSEcCtD
Tadalafil—Headache—Enalapril—hypertension	1.53e-05	0.000114	CcSEcCtD
Tadalafil—Pain—Timolol—hypertension	1.53e-05	0.000114	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—AKT2—hypertension	1.53e-05	0.000214	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3R1—hypertension	1.52e-05	0.000214	CbGpPWpGaD
Tadalafil—Rash—Telmisartan—hypertension	1.52e-05	0.000113	CcSEcCtD
Tadalafil—Dermatitis—Telmisartan—hypertension	1.52e-05	0.000113	CcSEcCtD
Tadalafil—Diarrhoea—Furosemide—hypertension	1.52e-05	0.000113	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Lisinopril—hypertension	1.51e-05	0.000113	CcSEcCtD
Tadalafil—Pruritus—Losartan—hypertension	1.51e-05	0.000112	CcSEcCtD
Tadalafil—Headache—Telmisartan—hypertension	1.51e-05	0.000112	CcSEcCtD
Tadalafil—Dizziness—Perindopril—hypertension	1.51e-05	0.000112	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP2C18—hypertension	1.51e-05	0.000211	CbGpPWpGaD
Tadalafil—Insomnia—Lisinopril—hypertension	1.5e-05	0.000112	CcSEcCtD
Tadalafil—Dizziness—Irbesartan—hypertension	1.5e-05	0.000112	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ADRB2—hypertension	1.5e-05	0.000211	CbGpPWpGaD
Tadalafil—Diarrhoea—Betaxolol—hypertension	1.5e-05	0.000112	CcSEcCtD
Tadalafil—Gastrointestinal pain—Ramipril—hypertension	1.5e-05	0.000111	CcSEcCtD
Tadalafil—Nausea—Clonidine—hypertension	1.5e-05	0.000111	CcSEcCtD
Tadalafil—Paraesthesia—Lisinopril—hypertension	1.49e-05	0.000111	CcSEcCtD
Tadalafil—Vomiting—Captopril—hypertension	1.49e-05	0.000111	CcSEcCtD
Tadalafil—Dizziness—Hydrochlorothiazide—hypertension	1.49e-05	0.000111	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	1.49e-05	0.000209	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCE—hypertension	1.48e-05	0.000208	CbGpPWpGaD
Tadalafil—Dyspnoea—Lisinopril—hypertension	1.48e-05	0.00011	CcSEcCtD
Tadalafil—Rash—Captopril—hypertension	1.48e-05	0.00011	CcSEcCtD
Tadalafil—Dermatitis—Captopril—hypertension	1.48e-05	0.00011	CcSEcCtD
Tadalafil—Somnolence—Lisinopril—hypertension	1.48e-05	0.00011	CcSEcCtD
Tadalafil—Headache—Captopril—hypertension	1.47e-05	0.000109	CcSEcCtD
Tadalafil—Gastrointestinal pain—Timolol—hypertension	1.47e-05	0.000109	CcSEcCtD
Tadalafil—Dizziness—Furosemide—hypertension	1.47e-05	0.000109	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PDGFA—hypertension	1.46e-05	0.000206	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VAV3—hypertension	1.46e-05	0.000206	CbGpPWpGaD
Tadalafil—Dyspepsia—Lisinopril—hypertension	1.46e-05	0.000109	CcSEcCtD
Tadalafil—Diarrhoea—Losartan—hypertension	1.46e-05	0.000109	CcSEcCtD
Tadalafil—Nausea—Trandolapril—hypertension	1.46e-05	0.000108	CcSEcCtD
Tadalafil—Urticaria—Ramipril—hypertension	1.46e-05	0.000108	CcSEcCtD
Tadalafil—Nausea—Enalapril—hypertension	1.45e-05	0.000108	CcSEcCtD
Tadalafil—Dizziness—Betaxolol—hypertension	1.45e-05	0.000108	CcSEcCtD
Tadalafil—Vomiting—Perindopril—hypertension	1.45e-05	0.000108	CcSEcCtD
Tadalafil—Abdominal pain—Ramipril—hypertension	1.45e-05	0.000108	CcSEcCtD
Tadalafil—Vomiting—Irbesartan—hypertension	1.44e-05	0.000107	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—TGFBR2—hypertension	1.44e-05	0.000203	CbGpPWpGaD
Tadalafil—Rash—Perindopril—hypertension	1.44e-05	0.000107	CcSEcCtD
Tadalafil—Dermatitis—Perindopril—hypertension	1.44e-05	0.000107	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Lisinopril—hypertension	1.44e-05	0.000107	CcSEcCtD
Tadalafil—Nausea—Telmisartan—hypertension	1.43e-05	0.000107	CcSEcCtD
Tadalafil—Fatigue—Lisinopril—hypertension	1.43e-05	0.000106	CcSEcCtD
Tadalafil—Vomiting—Hydrochlorothiazide—hypertension	1.43e-05	0.000106	CcSEcCtD
Tadalafil—Rash—Irbesartan—hypertension	1.43e-05	0.000106	CcSEcCtD
Tadalafil—Dermatitis—Irbesartan—hypertension	1.43e-05	0.000106	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GNB3—hypertension	1.43e-05	0.000201	CbGpPWpGaD
Tadalafil—Headache—Perindopril—hypertension	1.43e-05	0.000106	CcSEcCtD
Tadalafil—Urticaria—Timolol—hypertension	1.42e-05	0.000106	CcSEcCtD
Tadalafil—Headache—Irbesartan—hypertension	1.42e-05	0.000106	CcSEcCtD
Tadalafil—Constipation—Lisinopril—hypertension	1.42e-05	0.000106	CcSEcCtD
Tadalafil—Pain—Lisinopril—hypertension	1.42e-05	0.000106	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—TGFB1—hypertension	1.42e-05	0.0002	CbGpPWpGaD
Tadalafil—Rash—Hydrochlorothiazide—hypertension	1.42e-05	0.000106	CcSEcCtD
Tadalafil—Dermatitis—Hydrochlorothiazide—hypertension	1.42e-05	0.000105	CcSEcCtD
Tadalafil—Abdominal pain—Timolol—hypertension	1.42e-05	0.000105	CcSEcCtD
Tadalafil—Dizziness—Losartan—hypertension	1.41e-05	0.000105	CcSEcCtD
Tadalafil—Headache—Hydrochlorothiazide—hypertension	1.41e-05	0.000105	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—AVP—hypertension	1.41e-05	0.000198	CbGpPWpGaD
Tadalafil—Vomiting—Furosemide—hypertension	1.41e-05	0.000105	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—RHOA—hypertension	1.4e-05	0.000196	CbGpPWpGaD
Tadalafil—Rash—Furosemide—hypertension	1.4e-05	0.000104	CcSEcCtD
Tadalafil—Dermatitis—Furosemide—hypertension	1.4e-05	0.000104	CcSEcCtD
Tadalafil—Vomiting—Betaxolol—hypertension	1.39e-05	0.000104	CcSEcCtD
Tadalafil—Nausea—Captopril—hypertension	1.39e-05	0.000104	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GNAS—hypertension	1.39e-05	0.000196	CbGpPWpGaD
Tadalafil—Headache—Furosemide—hypertension	1.39e-05	0.000103	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	1.38e-05	0.000194	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3R1—hypertension	1.38e-05	0.000194	CbGpPWpGaD
Tadalafil—Rash—Betaxolol—hypertension	1.38e-05	0.000103	CcSEcCtD
Tadalafil—Dermatitis—Betaxolol—hypertension	1.38e-05	0.000103	CcSEcCtD
Tadalafil—Headache—Betaxolol—hypertension	1.37e-05	0.000102	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—APOB—hypertension	1.36e-05	0.000191	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Lisinopril—hypertension	1.36e-05	0.000101	CcSEcCtD
Tadalafil—Vomiting—Losartan—hypertension	1.36e-05	0.000101	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PTK2—hypertension	1.36e-05	0.000191	CbGpPWpGaD
Tadalafil—Nausea—Perindopril—hypertension	1.35e-05	0.000101	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—hypertension	1.35e-05	0.00019	CbGpPWpGaD
Tadalafil—Hypersensitivity—Ramipril—hypertension	1.35e-05	0.0001	CcSEcCtD
Tadalafil—Nausea—Irbesartan—hypertension	1.35e-05	0.0001	CcSEcCtD
Tadalafil—Rash—Losartan—hypertension	1.35e-05	0.0001	CcSEcCtD
Tadalafil—Dermatitis—Losartan—hypertension	1.35e-05	0.0001	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—EDN1—hypertension	1.34e-05	0.000188	CbGpPWpGaD
Tadalafil—Headache—Losartan—hypertension	1.34e-05	9.95e-05	CcSEcCtD
Tadalafil—Nausea—Hydrochlorothiazide—hypertension	1.34e-05	9.94e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCL5—hypertension	1.33e-05	0.000187	CbGpPWpGaD
Tadalafil—Urticaria—Lisinopril—hypertension	1.32e-05	9.81e-05	CcSEcCtD
Tadalafil—Hypersensitivity—Timolol—hypertension	1.32e-05	9.81e-05	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—GPX3—hypertension	1.32e-05	0.000185	CbGpPWpGaD
Tadalafil—Nausea—Furosemide—hypertension	1.32e-05	9.78e-05	CcSEcCtD
Tadalafil—Asthenia—Ramipril—hypertension	1.32e-05	9.77e-05	CcSEcCtD
Tadalafil—Abdominal pain—Lisinopril—hypertension	1.31e-05	9.77e-05	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—TP53—hypertension	1.31e-05	0.000184	CbGpPWpGaD
Tadalafil—Nausea—Betaxolol—hypertension	1.3e-05	9.68e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—LPL—hypertension	1.3e-05	0.000183	CbGpPWpGaD
Tadalafil—Pruritus—Ramipril—hypertension	1.3e-05	9.64e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—H2AFX—hypertension	1.29e-05	0.000182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RPS6KB1—hypertension	1.29e-05	0.000181	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDGFRB—hypertension	1.29e-05	0.000181	CbGpPWpGaD
Tadalafil—Asthenia—Timolol—hypertension	1.29e-05	9.55e-05	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—ALDH2—hypertension	1.28e-05	0.00018	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADCY5—hypertension	1.27e-05	0.000179	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	1.27e-05	0.000179	CbGpPWpGaD
Tadalafil—Nausea—Losartan—hypertension	1.27e-05	9.44e-05	CcSEcCtD
Tadalafil—Pruritus—Timolol—hypertension	1.27e-05	9.42e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PRKCG—hypertension	1.27e-05	0.000178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITGB3—hypertension	1.26e-05	0.000177	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCA—hypertension	1.26e-05	0.000177	CbGpPWpGaD
Tadalafil—Diarrhoea—Ramipril—hypertension	1.25e-05	9.32e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—YWHAZ—hypertension	1.25e-05	0.000175	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP11A1—hypertension	1.24e-05	0.000174	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGF—hypertension	1.23e-05	0.000173	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SPP1—hypertension	1.23e-05	0.000173	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—hypertension	1.23e-05	0.000172	CbGpPWpGaD
Tadalafil—Diarrhoea—Timolol—hypertension	1.23e-05	9.11e-05	CcSEcCtD
Tadalafil—Hypersensitivity—Lisinopril—hypertension	1.22e-05	9.1e-05	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	1.22e-05	0.000172	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—hypertension	1.22e-05	0.000171	CbGpPWpGaD
Tadalafil—Dizziness—Ramipril—hypertension	1.21e-05	9.01e-05	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GCLC—hypertension	1.2e-05	0.000169	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR5—hypertension	1.2e-05	0.000168	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCD—hypertension	1.2e-05	0.000168	CbGpPWpGaD
Tadalafil—Asthenia—Lisinopril—hypertension	1.19e-05	8.86e-05	CcSEcCtD
Tadalafil—Dizziness—Timolol—hypertension	1.19e-05	8.81e-05	CcSEcCtD
Tadalafil—Pruritus—Lisinopril—hypertension	1.18e-05	8.74e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—hypertension	1.17e-05	0.000165	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C3—hypertension	1.17e-05	0.000165	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—hypertension	1.17e-05	0.000164	CbGpPWpGaD
Tadalafil—Vomiting—Ramipril—hypertension	1.17e-05	8.66e-05	CcSEcCtD
Tadalafil—Rash—Ramipril—hypertension	1.16e-05	8.59e-05	CcSEcCtD
Tadalafil—Dermatitis—Ramipril—hypertension	1.15e-05	8.58e-05	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP17A1—hypertension	1.15e-05	0.000162	CbGpPWpGaD
Tadalafil—Headache—Ramipril—hypertension	1.15e-05	8.53e-05	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—PTGS1—hypertension	1.14e-05	0.00016	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDGFB—hypertension	1.14e-05	0.00016	CbGpPWpGaD
Tadalafil—Vomiting—Timolol—hypertension	1.14e-05	8.47e-05	CcSEcCtD
Tadalafil—Diarrhoea—Lisinopril—hypertension	1.14e-05	8.45e-05	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	1.14e-05	0.00016	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGFR1—hypertension	1.14e-05	0.000159	CbGpPWpGaD
Tadalafil—Rash—Timolol—hypertension	1.13e-05	8.4e-05	CcSEcCtD
Tadalafil—Dermatitis—Timolol—hypertension	1.13e-05	8.39e-05	CcSEcCtD
Tadalafil—Headache—Timolol—hypertension	1.12e-05	8.34e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—hypertension	1.12e-05	0.000157	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—hypertension	1.11e-05	0.000156	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—hypertension	1.11e-05	0.000156	CbGpPWpGaD
Tadalafil—Dizziness—Lisinopril—hypertension	1.1e-05	8.17e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CALM1—hypertension	1.1e-05	0.000154	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LEP—hypertension	1.09e-05	0.000153	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—hypertension	1.09e-05	0.000153	CbGpPWpGaD
Tadalafil—Nausea—Ramipril—hypertension	1.09e-05	8.09e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CAV1—hypertension	1.08e-05	0.000152	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA1—hypertension	1.08e-05	0.000152	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—hypertension	1.07e-05	0.00015	CbGpPWpGaD
Tadalafil—Nausea—Timolol—hypertension	1.06e-05	7.91e-05	CcSEcCtD
Tadalafil—Vomiting—Lisinopril—hypertension	1.06e-05	7.85e-05	CcSEcCtD
Tadalafil—Rash—Lisinopril—hypertension	1.05e-05	7.79e-05	CcSEcCtD
Tadalafil—Dermatitis—Lisinopril—hypertension	1.05e-05	7.78e-05	CcSEcCtD
Tadalafil—Headache—Lisinopril—hypertension	1.04e-05	7.74e-05	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	1.03e-05	0.000145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FN1—hypertension	1.03e-05	0.000145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2—hypertension	1.03e-05	0.000145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCB—hypertension	1.03e-05	0.000145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH1—hypertension	1.01e-05	0.000141	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—hypertension	9.88e-06	0.000139	CbGpPWpGaD
Tadalafil—Nausea—Lisinopril—hypertension	9.88e-06	7.34e-05	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—POMC—hypertension	9.38e-06	0.000132	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—INS—hypertension	9.32e-06	0.000131	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL2—hypertension	9.17e-06	0.000129	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP19A1—hypertension	9.12e-06	0.000128	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—hypertension	9.02e-06	0.000127	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT2—hypertension	9.01e-06	0.000127	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	9e-06	0.000126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—hypertension	8.97e-06	0.000126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—hypertension	8.56e-06	0.00012	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—COMT—hypertension	8.48e-06	0.000119	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—COMT—hypertension	8.37e-06	0.000117	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF2—hypertension	8.29e-06	0.000116	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RHOA—hypertension	8.26e-06	0.000116	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3R1—hypertension	8.18e-06	0.000115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—hypertension	8.18e-06	0.000115	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—hypertension	7.76e-06	0.000109	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RELA—hypertension	7.7e-06	0.000108	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	7.65e-06	0.000107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MTOR—hypertension	7.55e-06	0.000106	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP1A1—hypertension	7.35e-06	0.000103	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FAH—hypertension	7.26e-06	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	7.25e-06	0.000102	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—hypertension	7.25e-06	0.000102	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—hypertension	7.01e-06	9.84e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—hypertension	6.9e-06	9.68e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—hypertension	6.56e-06	9.21e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN1A—hypertension	6.54e-06	9.18e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTEN—hypertension	6.52e-06	9.16e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK8—hypertension	6.38e-06	8.96e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—hypertension	6.36e-06	8.93e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EP300—hypertension	6.22e-06	8.73e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SRC—hypertension	6.05e-06	8.49e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—hypertension	5.89e-06	8.27e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PNMT—hypertension	5.5e-06	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HAS3—hypertension	5.5e-06	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HAS1—hypertension	5.5e-06	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—QDPR—hypertension	5.5e-06	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HAS2—hypertension	5.5e-06	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HYAL2—hypertension	5.5e-06	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—POMC—hypertension	5.48e-06	7.7e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—hypertension	5.42e-06	7.61e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—hypertension	5.41e-06	7.59e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—hypertension	5.3e-06	7.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTA5—hypertension	5.17e-06	7.26e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HYAL1—hypertension	4.9e-06	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT2—hypertension	4.9e-06	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MDH1—hypertension	4.9e-06	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CDO1—hypertension	4.9e-06	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CPS1—hypertension	4.9e-06	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCH1—hypertension	4.68e-06	6.57e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP4F12—hypertension	4.68e-06	6.57e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCD1—hypertension	4.48e-06	6.3e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—hypertension	4.45e-06	6.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AHCY—hypertension	4.32e-06	6.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP11B1—hypertension	4.32e-06	6.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DBH—hypertension	4.17e-06	5.85e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GBA—hypertension	4.17e-06	5.85e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM5—hypertension	4.17e-06	5.85e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX12—hypertension	4.17e-06	5.85e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—EPHX2—hypertension	4.17e-06	5.85e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—hypertension	4.07e-06	5.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2J2—hypertension	4.04e-06	5.67e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COX5B—hypertension	3.92e-06	5.5e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLS2—hypertension	3.92e-06	5.5e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ARG1—hypertension	3.92e-06	5.5e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DECR1—hypertension	3.92e-06	5.5e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—hypertension	3.76e-06	5.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALAD—hypertension	3.72e-06	5.22e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCE1—hypertension	3.54e-06	4.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH7A1—hypertension	3.54e-06	4.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STS—hypertension	3.54e-06	4.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP4A11—hypertension	3.4e-06	4.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ARG2—hypertension	3.4e-06	4.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CBS—hypertension	3.4e-06	4.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—XDH—hypertension	3.33e-06	4.68e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC5A2—hypertension	3.27e-06	4.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP3A5—hypertension	3.27e-06	4.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGIS—hypertension	3.27e-06	4.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TPH1—hypertension	3.16e-06	4.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UCP3—hypertension	3.16e-06	4.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD11B1—hypertension	3.16e-06	4.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCC1—hypertension	3.16e-06	4.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UCP2—hypertension	3.16e-06	4.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP11B2—hypertension	3.06e-06	4.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC2A3—hypertension	3.06e-06	4.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALAS1—hypertension	3.06e-06	4.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD3B1—hypertension	3.01e-06	4.23e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADA—hypertension	3.01e-06	4.23e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AQP1—hypertension	2.97e-06	4.17e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FADS1—hypertension	2.97e-06	4.17e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA9—hypertension	2.89e-06	4.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TBXAS1—hypertension	2.89e-06	4.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX15—hypertension	2.82e-06	3.95e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5AP—hypertension	2.82e-06	3.95e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HADHA—hypertension	2.75e-06	3.86e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LHB—hypertension	2.75e-06	3.86e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPA—hypertension	2.69e-06	3.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD3B2—hypertension	2.69e-06	3.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—KCNJ11—hypertension	2.69e-06	3.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2C18—hypertension	2.58e-06	3.62e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LRP2—hypertension	2.58e-06	3.62e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSPG2—hypertension	2.48e-06	3.48e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5—hypertension	2.39e-06	3.36e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLP1R—hypertension	2.39e-06	3.36e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH2—hypertension	2.19e-06	3.07e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HBA1—hypertension	2.13e-06	3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP11A1—hypertension	2.12e-06	2.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC9A1—hypertension	2.08e-06	2.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—hypertension	2.08e-06	2.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCLC—hypertension	2.06e-06	2.89e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CETP—hypertension	2.06e-06	2.89e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP17A1—hypertension	1.97e-06	2.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ENO1—hypertension	1.95e-06	2.74e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS1—hypertension	1.95e-06	2.74e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CTGF—hypertension	1.88e-06	2.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT2—hypertension	1.86e-06	2.61e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMGCR—hypertension	1.86e-06	2.61e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADRA2A—hypertension	1.82e-06	2.56e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TH—hypertension	1.71e-06	2.4e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CALM2—hypertension	1.7e-06	2.39e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCG—hypertension	1.66e-06	2.33e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC2A4—hypertension	1.66e-06	2.33e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT1—hypertension	1.61e-06	2.26e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STK11—hypertension	1.56e-06	2.19e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP19A1—hypertension	1.56e-06	2.19e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COMT—hypertension	1.45e-06	2.04e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARGC1A—hypertension	1.43e-06	2.01e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNB3—hypertension	1.43e-06	2.01e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—hypertension	1.42e-06	2e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—hypertension	1.4e-06	1.97e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNAS—hypertension	1.39e-06	1.96e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOB—hypertension	1.36e-06	1.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—hypertension	1.33e-06	1.86e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPL—hypertension	1.3e-06	1.83e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADCY5—hypertension	1.27e-06	1.79e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX1—hypertension	1.27e-06	1.78e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PRKCA—hypertension	1.26e-06	1.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP1A1—hypertension	1.26e-06	1.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD36—hypertension	1.24e-06	1.74e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—hypertension	1.17e-06	1.65e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARA—hypertension	1.15e-06	1.62e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—hypertension	1.11e-06	1.56e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CALM1—hypertension	1.1e-06	1.54e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—hypertension	1.09e-06	1.53e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAV1—hypertension	1.08e-06	1.52e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—hypertension	1.08e-06	1.52e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—hypertension	9.51e-07	1.34e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—hypertension	9.38e-07	1.32e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INS—hypertension	9.33e-07	1.31e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—hypertension	8.55e-07	1.2e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—hypertension	8.18e-07	1.15e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3R1—hypertension	8.18e-07	1.15e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—hypertension	7.48e-07	1.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTEN—hypertension	6.52e-07	9.16e-06	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—EP300—hypertension	6.22e-07	8.73e-06	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—hypertension	3.76e-07	5.28e-06	CbGpPWpGaD
